Anti-12 Lipoxygenase/ALOX12 antibody
Be the first to review this product! Submit a review
|
(6 Publications)
Mouse Polyclonal 12 Lipoxygenase/ALOX12 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 6 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human ALOX12.
View Alternative Names
12LO, LOG12, ALOX12, Polyunsaturated fatty acid lipoxygenase ALOX12, Arachidonate (12S)-lipoxygenase, Arachidonate (15S)-lipoxygenase, Linoleate (13S)-lipoxygenase, Lipoxin synthase 12-LO, Platelet-type lipoxygenase 12, 12S-LOX, 12S-lipoxygenase
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-12 Lipoxygenase/ALOX12 antibody (AB167372)
Immunofluorescence analysis of HeLa cells labeling 12 Lipoxygenase/ALOX12 with ab167372 at 10μg/ml
- WB
Unknown
Western blot - Anti-12 Lipoxygenase/ALOX12 antibody (AB167372)
All lanes:
Western blot - Anti-12 Lipoxygenase/ALOX12 antibody (ab167372) at 1 µg/mL
Lane 1:
12 Lipoxygenase/ALOX12 transfected 293T cell lysate at 15 µL
Lane 2:
Non-transfected 293T cell lysate at 15 µL
Secondary
All lanes:
Goat Anti-Mouse IgG (H&L)-HRP at 1/2500 dilution
Predicted band size: 76 kDa
true
- WB
CiteAb
Western blot - Anti-12 Lipoxygenase/ALOX12 antibody (AB167372)
12 Lipoxygenase/ALOX12 western blot using anti-12 Lipoxygenase/ALOX12 antibody ab167372. Publication image and figure legend from Zhang, Q., Yan, G., et al., 2020, Mol Med, PubMed 32375633.
ab167372 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab167372 please see the product overview.
DDP-resistant ovarian cancer cells possess enhanced metastatic activity and arachidonic acid metabolism. a The procedure for the induction of DDP-resistant SKOV3 cells (upper panel); IC50 and the cell viabilities of SKOV3 and SKOV3-R with different concentrations of DDP treatment (lower panel). b, c The mRNA (b) and protein (c) levels of MRP1, MRP4, Slug and Snail in SKOV3 and SKOV3-R. d Liver metastasis in nude mice after SKOV3 or SKOV3-R subcutaneous transplantation. e, f. Migration and invasion of SKOV3 and SKOV3-R were tested by wound-healing (e) and transwell assays (f). g MRM chromatograms of AA, TXB2, 12-HETE, 5,6-EET, and 14,15-EET. h The supernatant levels of LTB4, 5-HETE, 12-HETE, PGE2, TXB2, 5,6-EET, 14,15-EET, 14,15-DHET, 11-HETE, and 11,12-DHET in SKOV3 and SKOV3-R. i The heatmap for gene expression of 12LOX, COX1, CYP2J2, COX2, 5LOX, 15LOX, LTA4H and PGDH. j the protein levels of 12LOX and COX1 were assessed by western blot. Data are expressed as mean ± SEM of 4 independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
12-LOX influences many cellular processes such as inflammation and thrombosis regulation. It is part of the lipoxygenase pathway synthesizing lipid signaling molecules that modulate immune responses and cellular growth. The enzyme does not form part of a large protein complex but interacts with lipid membranes where it exerts its catalytic function. Through its activity 12-LOX contributes to the production of eicosanoids which are signaling molecules with various physiological roles.
Pathways
12-LOX is involved in the arachidonic acid metabolism pathway and the eicosanoid signaling pathway. These pathways play roles in inflammation and immune response modulation. It works alongside other related lipoxygenases such as ALOX5 which produce different but related signaling molecules. The interaction between these enzymes helps maintain a balanced production of inflammatory mediators which controls cell proliferation and responses to external stimuli.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Phytotherapy research : PTR 38:5441-5457 PubMed39289784
2024
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 43:2337-2367 PubMed38649537
2024
Applications
Unspecified application
Species
Unspecified reactive species
Methods in molecular biology (Clifton, N.J.) 2712:211-222 PubMed37578709
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:800522 PubMed35002735
2021
Applications
Unspecified application
Species
Unspecified reactive species
Clinical epigenetics 12:66 PubMed32398127
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 26:39 PubMed32375633
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com